By Nicholas G. Miller

Shares of Perrigo slipped after the company posted second-quarter earnings and revenue below Wall Street's expectations.

The stock was down 13%, to $23.22, and is down 19% over the last 12 months.

The Irish over-the-counter health products company reported a loss of $8.4 million, or 6 cents a share, compared with a loss of $108.4 million, or 79 cents a share, a year prior.

Adjusted earnings were 57 cents a share. Wall Street expected 59 cents, according to FactSet.

The company reported $1.06 billion in revenue, a tick down from $1.07 billion the prior year. Analysts expected $1.08 billion. Top-line declines were fueled by a 1.9% fall in revenue from the company's Americas division. The company cited "a challenging consumer environment in the U.S. and the EU."

The company reaffirmed its full-year revenue guidance of flat to up 3%, but said it expected the lower end of that guidance, citing slower recovery in the company's infant-formula business and "challenging market consumption."

Write to Nicholas G. Miller at nicholas.miller@wsj.com

(END) Dow Jones Newswires

August 06, 2025 14:20 ET (18:20 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.